- Directors and Auditors
- Articles of Association
- General Meetings
- - Previous General Meetings
- Insider Trading
Cancer leader City of Hope selects DigniCap for community network in California
Dignitana AB today announces that City of Hope has selected DigniCap as the scalp cooling provider of choice for its community network of 12 cancer treatment centers in California. The DigniCap® Scalp Cooling System minimizes hair loss from chemotherapy in patients with solid tumors.
City of Hope National Medical Center in Duarte, California has used DigniCap since 2016 and in March 2020 DigniCap was installed at the newly constructed Newport Beach location. DigniCap will be available in City of Hope’s South Pasadena and Santa Clarita infusion centers before the end of the year, with additional locations receiving DigniCap next year.
“City of Hope is known for clinical excellence and their commitment to patient care. This expansion has been driven by patient demand in Southern California and the success that patients have with DigniCap. We are thrilled that more patients will now have access this life-changing treatment as we move even closer to scalp cooling becoming a standard of care,” said William Cronin, Dignitana CEO.
Founded in 1913, City of Hope is a National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network, making it a national leader in advancing research and treatment protocols.
Dignitana is the world leader in scalp cooling innovation providing the FDA-cleared DigniCap Scalp Cooling System in 30 states in the U.S. and 40 countries around the globe.
For More Information Contact
Melissa Bourestom, VP Corporate Communications firstname.lastname@example.org +1 469-518-5031
Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001. Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Certified Adviser is Redeye AB, +46 8 121 576 90, email@example.com and www.redeye.se. Learn more at www.dignitana.se and www.dignicap.com.